Welcome to Current Immunology, Today is
Antibody-drug conjugate OKT3-vcMMAE shows potent antitumor activity against CD3+ T cell malignancies
DING Xi-zhong, FAN Li-lü, HAN Ping, YANG Xuan-ming
Current Immunology . 2023, (4): 282 -288 .